Search research articles
Contact Us
Filters
Showing results (61-70 of 147) with videos related to
Page
of 15
Sort By:
Metabolites
|
September 13, 2018
Potential Metabolomic Linkage in Blood between Parkinson's Disease and Traumatic Brain Injury
Massimo S Fiandaca, Thomas J Gross, Thomas M Johnson, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)
|
April 8, 2020
Metabolic correlates of prevalent mild cognitive impairment and Alzheimer's disease in adults with Down syndrome
Mark Mapstone, Thomas J Gross, Fabio Macciardi, et al.
Journal of Alzheimer'S Disease : JAD
|
October 16, 2025
The joint association of obesity and physical activity on cognitive function in Down syndrome
Julianne G Clina, Brian C Helsel, Sigan L Hartley, et al.
Ageing Research Reviews
|
April 5, 2024
A critical appraisal of blood-based biomarkers for Alzheimer's disease
Simone Lista, Mark Mapstone, Filippo Caraci, et al.
Journal of Intellectual Disability Research : JIDR
|
April 21, 2025
Modified Cued Recall Test: Longitudinal Analysis of Test Versions and Item Recall in Adults With Down Syndrome
Emily K Schworer, Benjamin L Handen, Sharon Krinsky-McHale, et al.
Ebiomedicine
|
January 10, 2025
Mid-life anti-inflammatory metabolites are inversely associated with long-term cardiovascular disease events
Anum Saeed, Chris McKennan, Jiaxuan Duan, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
May 31, 2021
A blood screening tool for detecting mild cognitive impairment and Alzheimer's disease among community-dwelling Mexican Americans and non-Hispanic Whites: A method for increasing representation of diverse populations in clinical research
Sid E O'Bryant, Fan Zhang, Melissa Petersen, et al.
Frontiers in Neurology
|
December 1, 2015
Plasma 24-metabolite Panel Predicts Preclinical Transition to Clinical Stages of Alzheimer's Disease
Massimo S Fiandaca, Xiaogang Zhong, Amrita K Cheema, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
October 17, 2025
Examination of metabolic syndrome in Down syndrome and association with dementia
Dina Dass, Lam-Ha T Dang, Laura Xicota, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
July 13, 2023
Plasma NT1-tau and Aβ<sub>42</sub> correlate with age and cognitive function in two large Down syndrome cohorts
Andrew M Stern, Kathryn L Van Pelt, Lei Liu, et al.
Page
of 15
Search research articles
Search
Showing results (61-70 of 147) with videos related to
Sort By:
Page
of 15
Metabolites
|
September 13, 2018
Potential Metabolomic Linkage in Blood between Parkinson's Disease and Traumatic Brain Injury
Massimo S Fiandaca, Thomas J Gross, Thomas M Johnson, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)
|
April 8, 2020
Metabolic correlates of prevalent mild cognitive impairment and Alzheimer's disease in adults with Down syndrome
Mark Mapstone, Thomas J Gross, Fabio Macciardi, et al.
Journal of Alzheimer'S Disease : JAD
|
October 16, 2025
The joint association of obesity and physical activity on cognitive function in Down syndrome
Julianne G Clina, Brian C Helsel, Sigan L Hartley, et al.
Ageing Research Reviews
|
April 5, 2024
A critical appraisal of blood-based biomarkers for Alzheimer's disease
Simone Lista, Mark Mapstone, Filippo Caraci, et al.
Journal of Intellectual Disability Research : JIDR
|
April 21, 2025
Modified Cued Recall Test: Longitudinal Analysis of Test Versions and Item Recall in Adults With Down Syndrome
Emily K Schworer, Benjamin L Handen, Sharon Krinsky-McHale, et al.
Ebiomedicine
|
January 10, 2025
Mid-life anti-inflammatory metabolites are inversely associated with long-term cardiovascular disease events
Anum Saeed, Chris McKennan, Jiaxuan Duan, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
May 31, 2021
A blood screening tool for detecting mild cognitive impairment and Alzheimer's disease among community-dwelling Mexican Americans and non-Hispanic Whites: A method for increasing representation of diverse populations in clinical research
Sid E O'Bryant, Fan Zhang, Melissa Petersen, et al.
Frontiers in Neurology
|
December 1, 2015
Plasma 24-metabolite Panel Predicts Preclinical Transition to Clinical Stages of Alzheimer's Disease
Massimo S Fiandaca, Xiaogang Zhong, Amrita K Cheema, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
October 17, 2025
Examination of metabolic syndrome in Down syndrome and association with dementia
Dina Dass, Lam-Ha T Dang, Laura Xicota, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
July 13, 2023
Plasma NT1-tau and Aβ<sub>42</sub> correlate with age and cognitive function in two large Down syndrome cohorts
Andrew M Stern, Kathryn L Van Pelt, Lei Liu, et al.
Page
of 15